TSHA vs ABCL
Comparison between Taysha Gene Therapies Inc (TSHA, Company) and AbCellera Biologics Inc (ABCL, Company).
Both TSHA and ABCL are from the Healthcare sector.
5-Year PerformanceTSHA has outperformed ABCL, delivering a return of -25.3% compared to -27.3%
TSHA vs ABCL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
TSHA vs ABCL - Historical Returns
Returns include dividend reinvestment.
TSHA vs ABCL - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | TSHA | ABCL |
|---|---|---|
| 2026 | +8.76% | +52.77% |
| 2025 | +197.30% | +12.87% |
| 2024 | +1.17% | -48.87% |
| 2023 | -19.55% | -39.83% |
| 2022 | -80.94% | -28.36% |
| 2021 | -55.48% | -63.43% |
| 2020 | +10.31% | -31.68% |
TSHA vs ABCL Drawdown Comparison
The maximum drawdown for TSHA was -98.14%, occurring on Jun 28, 2023. This drawdown has not yet recovered.
The maximum drawdown for ABCL was -96.72%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current TSHA drawdown is -82.02%. The current ABCL drawdown is -91.10%.
| Rank | TSHA | ABCL |
|---|---|---|
| #1 | -98.14% Jan 20, 2021 - Jun 28, 2023 | -96.72% Dec 11, 2020 - Apr 8, 2025 |
| #2 | -21.78% Sep 25, 2020 - Dec 23, 2020 | N/A |
| #3 | -10.74% Dec 23, 2020 - Jan 14, 2021 | N/A |
Correlation
Correlation between TSHA and ABCL is 0.89 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks